pharma · Duchenne Muscular Dystrophy · Muscular Dystrophy, Duchenne · SRPT
Sarepta Therapeutics
News and analysis for Sarepta Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
215 First Street, Cambridge, MA 02142, US HQ
1,150 Employees
Public company Type
SRPT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 215 First Street, Cambridge, MA 02142, US
- Employees
- 1,150
- Programs
- 46
- Drugs
- 23
- Patents
- 102
News & analysis
NovaPharmaNews articles mentioning Sarepta Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Sarepta Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.